F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy

Gynecologic Oncology

Volumn 101, Issue 1, 2006, Pages 147-151

  Xue, Feiyu ^a   Lin, Lilie L ^a   Dehdashti, Farrokh ^a,b   Miller, Tom R ^a,b   Siegel, Barry A ^a,b   Grigsby, Perry W ^a,b,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b USA   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cervical cancer; FDG; SUV

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG UPTAKE; EVALUATION; FEMALE; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METABOLISM; MULTIVARIATE ANALYSIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; UNIVARIATE ANALYSIS; UTERINE CERVIX CANCER;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; UTERINE CERVICAL NEOPLASMS;

EID: 33644501479     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.10.005     Document Type: Article

References (27)

1. E.M. Rohren, T.G. Turkington, and R.E. Coleman Clinical applications of PET in oncology Radiology 231 2004 305 332
2. P.W. Grigsby, F. Dehdashti, and B.A. Siegel FDG-PET evaluation of carcinoma of the cervix Clin. Pos. Imag. 2 1999 105 109
3. P.W. Grigsby, B.A. Siegel, and F. Dehdashti Lymph node staging by positron emission tomography in patients with carcinoma of the cervix J. Clin. Oncol. 19 2001 3745 3749
4. 18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome J. Clin. Oncol. 22 2004 2167 2171
5. P.G. Rose, L.P. Adler, M. Rodriguez, P.F. Faulhaber, F.W. Abdul-Karim, and F. Miraldi Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study J. Clin. Oncol. 17 1999 41 45
6. T.Z. Wong, E.L. Jones, and R.E. Coleman Positron emission tomography with 2-deoxy-2-[(18)F]fluoro-d-glucose for evaluating local and distant disease in patients with cervical cancer Mol. Imag. Biol. 6 2004 55 62
7. T.R. Miller, and P.W. Grigsby Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy Int. J. Radiat. Oncol. Biol. Phys. 53 2002 353 359
8. T.R. Miller, E. Pinkus, F. Dehdashti, and P.W. Grigsby Improved prognostic value of 18F-FDG PET using a simple visual analysis of tumor characteristics in patients with cervical cancer J. Nucl. Med. 44 2003 192 197
9. 18F] Fluoro-2-deoxy-d- glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy J. Clin. Oncol. 20 2002 1398 1404
10. J.F. Vansteenkiste, S.G. Stroobants, P.J. Dupont, P.R. De Leyn, E.K. Verbeken, and G.J. Deneffe Prognostic importance of the standardized uptake value on 18F-Fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: an analysis of 125 cases J. Clin. Oncol. 17 1999 3201 3206
11. C. Perez Uterine cervix C. Perez L. Brady Principles and Practice of Radiation Oncology 2nd ed. 1992 J.B. Lippincott Philadelphia 1143 1202
12. C.J. Hoekstra, I. Paglianiti, O.S. Hoekstra, E.F. Smit, P.E. Postmus, and G.J.J. Teule Monitoring response to therapy in cancer using [18F]-2-fluoro-2-deoxy-d-glucose and positron emission tomography: an overview of different analytical methods Eur. J. Nucl. Med. 27 2000 731 743
13. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J. Am. Stat. Assoc. 53 1958 457 481
14. D.R. Cox Regression models and life tables J. R. Stat. Soc. 34 1972 187 220
15. Y. Sugawara, A. Eisbruch, S. Kosuda, B.E. Recker, P.V. Kison, and R.L. Wahl Evaluation of FDG PET in patients with cervical cancer J. Nucl. Med. 40 1999 1125 1131
16. M. Mueckler Facilitative glucose transporters Eur. J. Biochem. 219 1994 713 725
17. L.E. Mendez, N. Manci, G. Cantuaria, O. Gomez-Marin, M. Penalver, and P. Braunschweiger Expression of glucose transporter-1 in cervical cancer and its precursors Gynecol. Oncol. 86 2002 138 143
18. R. Airley, J. Loncaster, S. Davidson, M. Bromley, S. Roberts, and A. Patterson Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix Clin. Cancer Res. 7 2001 928 934
19. T.-C. Yen, L.-C. See, C.-H. Lai, C.W. Yah-Huei, K.-K. Ng, and S.-Y. Ma 18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression J. Nucl. Med. 45 2004 22 29
20. W.A. Weber, V. Petersen, B. Schmidt, L. Tyndale-Hines, T. Link, and C. Peschel Positron emission tomography in non-small-cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use J. Clin. Oncol. 21 2003 2651 2657
21. Y. Nakamoto, A. Eisbruch, E.D. Achtyes, Y. Sugawara, K.R. Reynolds, and C.M. Johnston Prognostic value of positron emission tomography using F-18-fluorodeoxyglucose in patients with cervical cancer undergoing radiotherapy Gynecol. Oncol. 84 2002 289 295
22. H. Minn, H. Joensuu, A. Ahonen, and P. Klemi Fluorodeoxyglucose imaging: a method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors Cancer 61 1988 1776 1781
23. U. Haberkorn, L.G. Strauss, C. Reisser, D. Haag, A. Dimitrakopoulou, and S. Ziegler Glucose uptake, perfusion, and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry J. Nucl. Med. 32 1991 1555 1558
24. H. Minn, A.C. Clavo, R. Grenman, and R.L. Wahl In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and L-methionine in squamous-cell carcinoma of the head and neck J. Nucl. Med. 36 1995 252 258
25. M. Lapela, S. Leskinen, H. Minn, P. Lindholm, P. Klemi, and K. Soderstrom Increased glucose metabolism in untreated non-Hodgkin's lymphoma: a study with positron emission tomography and fluorine-18-fluorodeoxyglucose Blood 86 1995 3522 3527
26. A.C. Buck, H.H. Schirrmeister, C.-A. Guhlmann, C.G. Diederichs, C. Shen, and I. Buchmann Ki-67 Immunostaining in pancreatic cancer and chronic active pancreatitis: does in vivo FDG uptake correlate with proliferative activity? J. Nucl. Med. 42 2001 721 725
27. Y. Yoshida, T. Kurokawa, K. Kawahara, A. Yagihara, T. Tsuchida, and H. Okazawa Metabolic monitoring of advanced uterine cervical cancer neoadjuvant chemotherapy by using [F-18]-Fluorodeoxyglucose positron emission tomography: preliminary results in three patients Gynecol. Oncol. 95 2004 597 602